Crist, Sarah B.
Azzag, Karim
Kiley, James
Coleman, Ilsa
Magli, Alessandro
Perlingeiro, Rita C. R. http://orcid.org/0000-0001-9412-1118
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR078571, R01 AR078624, R01 AR081882)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32 HL144472)
Greg Marzolf Junior Research Foundation - research grant; Lillehei Heart Institute - seed grant
Article History
Received: 30 October 2023
Accepted: 26 March 2024
First Online: 4 April 2024
Competing interests
: R.C.R.P. is co-founder of, has equity in, and serves on the Board of Directors of Myogenica, Inc. A.M. is a Sanofi employee. R.C.R.P. is an inventor of Patent No.: US 11,697,798 B2 and R.C.R.P. and A.M. are inventors of Patent Application #20160306. All other authors declare no competing interests.